DANAMECO Medical Joint Stock Corporation

HNX:DNM Stock Report

Market Cap: ₫96.1b

DANAMECO Medical Past Earnings Performance

Past criteria checks 0/6

DANAMECO Medical's earnings have been declining at an average annual rate of -22.6%, while the Medical Equipment industry saw earnings growing at 14.9% annually. Revenues have been growing at an average rate of 17% per year.

Key information

-22.6%

Earnings growth rate

-81.4%

EPS growth rate

Medical Equipment Industry Growth12.3%
Revenue growth rate17.0%
Return on equity-105.1%
Net Margin-32.8%
Last Earnings Update31 Mar 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How DANAMECO Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

HNX:DNM Revenue, expenses and earnings (VND Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 23239,555-78,68534,6060
31 Dec 22333,974-39,63838,1190
30 Sep 22473,794-25,42746,6330
30 Jun 22599,85838,98648,1240
31 Mar 22620,69540,75051,6100
31 Dec 21546,75530,10248,3650
30 Sep 21448,83712,05538,2780
30 Jun 21478,6119,82472,6710
31 Mar 21644,62327,58679,1590
31 Dec 20701,36431,17883,5740
30 Sep 20778,82637,05289,9390
30 Jun 20634,02231,23451,7070
31 Mar 20444,36415,78937,4560
31 Dec 19356,0798,68333,6090
30 Sep 19201,0975,37028,9250
30 Jun 19179,6674,72231,0180
31 Mar 19169,6754,35432,1950
31 Dec 18162,8954,13530,6280
30 Sep 18157,2133,76531,2240
31 Mar 18152,3057,20430,2990
31 Dec 17171,21610,94829,8510
30 Sep 17237,28613,83831,0790
31 Dec 16226,09815,22429,2710
30 Sep 16192,55017,10729,8230
31 Dec 15183,06414,85327,6910
30 Sep 15172,16611,92727,4700
30 Jun 15174,00213,28028,3480
31 Mar 15215,09719,48734,1440
31 Dec 14219,73220,09435,1640
30 Sep 14232,41725,68238,3440
30 Jun 14239,01424,43839,5820
31 Mar 14199,43618,37438,9290
31 Dec 13209,39718,62039,8200
31 Dec 12219,57612,85744,8160

Quality Earnings: DNM is currently unprofitable.

Growing Profit Margin: DNM is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: DNM is unprofitable, and losses have increased over the past 5 years at a rate of 22.6% per year.

Accelerating Growth: Unable to compare DNM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: DNM is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-3.2%).


Return on Equity

High ROE: DNM has a negative Return on Equity (-105.13%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.